Arrowstreet Capital Limited Partnership Has $6.76 Million Stake in Phibro Animal Health Co. (NASDAQ:PAHC)

Arrowstreet Capital Limited Partnership increased its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 35.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 322,090 shares of the company’s stock after purchasing an additional 84,599 shares during the period. Arrowstreet Capital Limited Partnership owned approximately 0.80% of Phibro Animal Health worth $6,764,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the company. Quantbot Technologies LP boosted its position in shares of Phibro Animal Health by 65.1% during the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company’s stock worth $107,000 after buying an additional 2,018 shares during the period. New York State Teachers Retirement System boosted its position in Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock worth $114,000 after acquiring an additional 775 shares during the last quarter. Amundi grew its stake in shares of Phibro Animal Health by 185.5% during the 4th quarter. Amundi now owns 9,855 shares of the company’s stock worth $212,000 after acquiring an additional 6,403 shares in the last quarter. Zacks Investment Management acquired a new stake in shares of Phibro Animal Health in the third quarter valued at approximately $274,000. Finally, SG Americas Securities LLC lifted its position in shares of Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company’s stock worth $276,000 after purchasing an additional 906 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on PAHC. StockNews.com lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th. Barclays upped their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Finally, Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company. Based on data from MarketBeat.com, Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $21.00.

Phibro Animal Health Price Performance

NASDAQ:PAHC opened at $19.19 on Monday. Phibro Animal Health Co. has a 12-month low of $12.30 and a 12-month high of $26.55. The firm has a market capitalization of $777.25 million, a price-to-earnings ratio of 39.98, a P/E/G ratio of 0.45 and a beta of 0.58. The stock’s 50 day moving average price is $22.71 and its two-hundred day moving average price is $22.65. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were issued a $0.12 dividend. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.50%. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.